Novo Nordisk's Retatrutide Australia: A Potential Solution for Obesity Management ?
Australia is a significant epidemic of excess weight, and a introduction of Retatrutide offers a exciting strategy for intervention. This unique medication, developed by the company Novo Nordisk , integrates the mechanisms of dual hormones – GLP-1 and GIP – to regulate appetite and promote feelin